ARCHIVES

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

This article is from The Cancer Letter archive.

Vol. 03 No. 03 | January 21, 1977

Download PDF Visit The Full Archive

Related Articles

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011

BRMP Proposals for Thymosins Development

November 30, 1979

Literature Review Supports Need for More Research In Cancer Control

July 19, 1985

ACS Study Shows Reduced Mortality For Low T/N Brands

April 18, 1980

In Brief: Reagan Names Hammer to Third Term As Cancer Panel chairman; RPMI Opens Survivor Clinic

July 31, 1987